高级检索
当前位置: 首页 > 详情页

Quantifying Etheno-DNA Adducts in Human Tissues, White Blood Cells, and Urine by Ultrasensitive 32P-Postlabeling and Immunohistochemistry

文献详情

资源类型:
WOS体系:
单位: [1]German Canc Res Ctr, Div Toxicol & Canc Risk Factors, Heidelberg, Germany [2]Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China [4]German Canc Res Ctr, Div Epigenom & Canc Risk Factor, Heidelberg, Germany
出处:
ISSN:

关键词: Etheno-DNA adducts Ultrasensitive detection Oxidative stress Lipid peroxidation Carcinogenesis Chronic degenerative diseases Human biomonitoring

摘要:
Exocyclic etheno-DNA adducts are formed by the reaction of lipid peroxidation products, such as 4-hydroxy-2-nonenal (HNE) with DNA bases to yield 1,N-6-etheno-2'-deoxyadenosine (epsilon dA), 3,N-4-etheno-2'-deoxycytidine (epsilon dC), and etheno-2'-deoxyguanosine. These adducts act as a driving force for many human malignancies and are elevated in the organs of cancer-prone patients suffering from chronic inflammation and infections. Here, we describe the ultrasensitive and specific techniques for the detection of epsilon dA and epsilon dC in tissue and white blood cell (WBC) DNA. This approach is based on combined immunopurification by monoclonal antibodies and P-32-postlabeling analysis. The detection limit is about five adducts per 10(10) parent nucleotides, requiring 5-10 mu g of DNA. In addition, we describe techniques for immunohistochemical detection of epsilon dA and epsilon dC in tissue biopsies, and the approaches for the analysis of epsilon dA and epsilon dC excreted in urine. The utility of these detection methods for human studies is based on: (1) high sensitivity and specificity, (2) low amounts of DNA required, (3) capability to detect "background" levels of etheno DNA adducts in biopsies, WBC, and urine samples of healthy subjects, and (4) reliable monitoring of the disease-related increase of these substances in patients. The described methods are useful in diagnosis and monitoring of chronic degenerative diseases, including cancer, atherosclerosis, and neurodegenerative disorders.

语种:
被引次数:
WOS:
PubmedID:
第一作者:
第一作者单位: [1]German Canc Res Ctr, Div Toxicol & Canc Risk Factors, Heidelberg, Germany
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:2 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)